Thrombopoietin Receptor (Mpl) Trafficking Defects in Congenital Amegakaryocytic Thrombocytopenia (CAMT) Caused by a Novel Double MPL K39N/W272R Mutation and Rescue Strategies via Autophagy and CRISPR-Cas9 Gene Editing